A Review of Unfractionated Heparin and Its Monitoring
Adjustment of unfractionated heparin dosage based on the aPTT (adapted... | Download Table
Baseline APPT, APTT-Heparin Slopes, and Heparin-APTT Doubling... | Download Table
View Image
Venous Thromboembolism (VTE) in the Hospitalized Patient | 2002-07-15…
Accuracy of aPTT monitoring in critically ill patients treated with unfractionated heparin. | Semantic Scholar
Summary of the PT and APTT values in the citrate adjusted and... | Download Table
Parenteral Anticoagulants - CHEST
Table 2 from Discordant aPTT and Anti-Xa Values and Outcomes in Hospitalized Patients Treated with Intravenous Unfractionated Heparin | Semantic Scholar
Time Required to Obtain Therapeutic APTT Result After a Nontherapeutic... | Download Table
Addressing clinical etiologies of a prolonged aPTT
Heparin dose adjustment required to maintain goal-activated partial thromboplastin time during therapeutic hypothermia - ScienceDirect
CCU - Unfractionated Heparin Protocol #CCU_DRUG... | Facebook
Table 1 from Heparin Therapy in Pediatric Patients: A Prospective Cohort Study | Semantic Scholar
Heparin Considerations for Use*
Heparin Nomogram - Heparin Dosing By Nomogram Physician's Orders Heparin Nomograms Form No. 61885 - StuDocu
JCM | Free Full-Text | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
Biomedicines | Free Full-Text | Updates in Anticoagulation Therapy Monitoring | HTML
Table 2 from Clinical considerations of heparinization. | Semantic Scholar
Table 2 from A Weight-Based Heparin Protocol for Improved Anticoagulation in a Coronary Care Unit | Semantic Scholar
Activated Partial Thromboplastin Time - an overview | ScienceDirect Topics
Unfractionated Heparin Infusion Chart
JCM | Free Full-Text | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
Heparin Protocol
When should low-molecular- weight heparin be monitored?